BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 21213395)

  • 1. Ganoderma lucidum polysaccharides: immunomodulation and potential anti-tumor activities.
    Xu Z; Chen X; Zhong Z; Chen L; Wang Y
    Am J Chin Med; 2011; 39(1):15-27. PubMed ID: 21213395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-tumor and immunoregulatory activities of Ganoderma lucidum and its possible mechanisms.
    Lin ZB; Zhang HN
    Acta Pharmacol Sin; 2004 Nov; 25(11):1387-95. PubMed ID: 15525457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ganoderma lucidum polysaccharide used for treating physical frailty in China.
    Zeng P; Chen Y; Zhang L; Xing M
    Prog Mol Biol Transl Sci; 2019; 163():179-219. PubMed ID: 31030748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms of bioactive polysaccharides from Ganoderma lucidum (Lingzhi), a review.
    Lu J; He R; Sun P; Zhang F; Linhardt RJ; Zhang A
    Int J Biol Macromol; 2020 May; 150():765-774. PubMed ID: 32035956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ganoderma lucidum Polysaccharides as An Anti-cancer Agent.
    Sohretoglu D; Huang S
    Anticancer Agents Med Chem; 2018; 18(5):667-674. PubMed ID: 29141563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity and underlying mechanisms of ganopoly, the refined polysaccharides extracted from Ganoderma lucidum, in mice.
    Gao Y; Gao H; Chan E; Tang W; Xu A; Yang H; Huang M; Lan J; Li X; Duan W; Xu C; Zhou S
    Immunol Invest; 2005; 34(2):171-98. PubMed ID: 15921158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical, biochemical, preclinical and clinical studies of Ganoderma lucidum polysaccharide as an approved drug for treating myopathy and other diseases in China.
    Zeng P; Guo Z; Zeng X; Hao C; Zhang Y; Zhang M; Liu Y; Li H; Li J; Zhang L
    J Cell Mol Med; 2018 Jul; 22(7):3278-3297. PubMed ID: 29691994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of water-soluble Ganoderma lucidum polysaccharides on the immune functions of patients with advanced lung cancer.
    Gao Y; Tang W; Dai X; Gao H; Chen G; Ye J; Chan E; Koh HL; Li X; Zhou S
    J Med Food; 2005; 8(2):159-68. PubMed ID: 16117607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ganopoly (a Ganoderma lucidum polysaccharide extract) on the immune functions in advanced-stage cancer patients.
    Gao Y; Zhou S; Jiang W; Huang M; Dai X
    Immunol Invest; 2003 Aug; 32(3):201-15. PubMed ID: 12916709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor and Immunomodulatory Activities of Ganoderma lucidum Polysaccharides in Glioma-Bearing Rats.
    Wang C; Shi S; Chen Q; Lin S; Wang R; Wang S; Chen C
    Integr Cancer Ther; 2018 Sep; 17(3):674-683. PubMed ID: 29607690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of proliferation and oxidative stress by extracts of Ganoderma lucidum in the ovarian cancer cell line OVCAR-3.
    Hsieh TC; Wu JM
    Int J Mol Med; 2011 Dec; 28(6):1065-9. PubMed ID: 21887458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular and molecular mechanisms of immuno-modulation by Ganoderma lucidum.
    Lin ZB
    J Pharmacol Sci; 2005 Oct; 99(2):144-53. PubMed ID: 16230843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune receptors for polysaccharides from Ganoderma lucidum.
    Shao BM; Dai H; Xu W; Lin ZB; Gao XM
    Biochem Biophys Res Commun; 2004 Oct; 323(1):133-41. PubMed ID: 15351712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enteric mucosal immune response might trigger the immunomodulation activity of Ganoderma lucidum polysaccharide in mice.
    Zhao H; Luo Y; Lu C; Lin N; Xiao C; Guan S; Guo DA; Liu Z; Ju D; He X; Lu A
    Planta Med; 2010 Feb; 76(3):223-7. PubMed ID: 19708002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum amyloid A mediates the inhibitory effect of Ganoderma lucidum polysaccharides on tumor cell adhesion to endothelial cells.
    Li YB; Wang R; Wu HL; Li YH; Zhong LJ; Yu HM; Li XJ
    Oncol Rep; 2008 Sep; 20(3):549-56. PubMed ID: 18695905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ganoderma lucidum and its pharmaceutically active compounds.
    Boh B; Berovic M; Zhang J; Zhi-Bin L
    Biotechnol Annu Rev; 2007; 13():265-301. PubMed ID: 17875480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor and anti-inflammatory activities of polysaccharides isolated from Ganoderma lucidum.
    Joseph S; Sabulal B; George V; Antony KR; Janardhanan KK
    Acta Pharm; 2011 Sep; 61(3):335-42. PubMed ID: 21945912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ganoderma lucidum: a potent pharmacological macrofungus.
    Sanodiya BS; Thakur GS; Baghel RK; Prasad GB; Bisen PS
    Curr Pharm Biotechnol; 2009 Dec; 10(8):717-42. PubMed ID: 19939212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of migration and induction of apoptosis in LoVo human colon cancer cells by polysaccharides from Ganoderma lucidum.
    Liang ZE; Yi YJ; Guo YT; Wang RC; Hu QL; Xiong XY
    Mol Med Rep; 2015 Nov; 12(5):7629-36. PubMed ID: 26397202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ganoderma lucidum suppresses growth of breast cancer cells through the inhibition of Akt/NF-kappaB signaling.
    Jiang J; Slivova V; Harvey K; Valachovicova T; Sliva D
    Nutr Cancer; 2004; 49(2):209-16. PubMed ID: 15489214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.